| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIONOMICS LTD/ADR | 10%+ Owner | Ordinary Shares | 183M | $60.4M | $0.33 | Jul 1, 2024 | By Apeiron Investment Group Ltd. |
| BIONOMICS LTD/ADR | 10%+ Owner | Ordinary Shares | 93.4M | $30.8M | $0.33 | Oct 4, 2024 | By Apeiron Presight Capital Fund II, L.P. |
| Alto Neuroscience, Inc. | Other* | Common Stock | 675K | Feb 6, 2024 | By Apeiron Presight Capital Fund II, L.P.( | ||
| Alto Neuroscience, Inc. | Other* | Common Stock | 252K | Feb 6, 2024 | Direct | ||
| ATAI Life Sciences N.V. | 10%+ Owner | Convertible Notes | 148K | Apr 15, 2024 | By Apeiron Investment Group Ltd. | ||
| Alto Neuroscience, Inc. | Other* | Series A Preferred Stock | 0 | Feb 6, 2024 | By Apeiron Presight Capital Fund II, L.P. | ||
| Alto Neuroscience, Inc. | Other* | Series A Preferred Stock | 0 | Feb 6, 2024 | Direct | ||
| Alto Neuroscience, Inc. | Other* | Series B Preferred Stock | 0 | Feb 6, 2024 | By Apeiron Presight Capital Fund II, L.P. | ||
| Alto Neuroscience, Inc. | Other* | Warrants to Purchase Series A Preferred Stock | 0 | Feb 6, 2024 | Direct | ||
| Sensei Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0.85 | Jun 1, 2023 | By Apeiron Investment Group Ltd. | |
| Sensei Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0.85 | Jun 1, 2023 | By Presight Sensei Co-Invest Fund, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BNOX | BIONOMICS LTD/ADR | Jul 1, 2024 | 3 | -$82.5K | 4 | Oct 7, 2024 | 10%+ Owner |
| BNOX | BIONOMICS LTD/ADR | Jul 1, 2024 | 0 | $0 | 3 | Oct 7, 2024 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 15, 2024 | 2 | $0 | 4 | Apr 17, 2024 | 10%+ Owner |
| ANRO | Alto Neuroscience, Inc. | Feb 6, 2024 | 6 | $0 | 4 | Mar 6, 2024 | Other* |
| SNSE | Sensei Biotherapeutics, Inc. | Jun 1, 2023 | 2 | -$5.44M | 4 | Jun 2, 2023 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Mar 29, 2023 | 1 | $1.6M | 4 | Mar 29, 2023 | 10%+ Owner |
| SNSE | Sensei Biotherapeutics, Inc. | Feb 23, 2023 | 2 | $3.54K | 4 | Feb 27, 2023 | 10%+ Owner |
| ANRO | Alto Neuroscience, Inc. | Feb 1, 2023 | 0 | $0 | 3 | Feb 2, 2024 | 10%+ Owner |
| SNSE | Sensei Biotherapeutics, Inc. | Jul 14, 2022 | 0 | $0 | 3 | Jul 20, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 28, 2022 | 2 | $252K | 4 | May 2, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 26, 2022 | 2 | $309K | 4 | Apr 28, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 22, 2022 | 2 | $298K | 4 | Apr 26, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 20, 2022 | 2 | $685K | 4 | May 3, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 18, 2022 | 2 | $612K | 4 | Apr 20, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 14, 2022 | 1 | $25.8K | 4 | Apr 18, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 12, 2022 | 1 | $270K | 4 | Apr 14, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 8, 2022 | 2 | $538K | 4 | Apr 12, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Apr 6, 2022 | 1 | $960K | 4 | Apr 7, 2022 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Jun 22, 2021 | 1 | $10.5M | 4 | Jun 24, 2021 | 10%+ Owner |
| ATAI | ATAI Life Sciences N.V. | Jun 17, 2021 | 0 | $0 | 3/A | Aug 25, 2021 | 10%+ Owner |